Avation Medical
Valencia, US · Founded 2016 · Delaware corporation · 3 known investors
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions. The device is prescribed by healthcare providers for patients seeking a non-invasive alternative to medications, injectables, or surgical implants.
Founders & leadership
JS
Jill SchiaparelliExecutive Officer, Director
TS
Thomas Shehab, MDDirector
KW
Kevin WassersteinDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$12.9MraisedFeb 2021 · 17 investors · Other Health CareRule 506(b)
▶$12.9MraisedFeb 2021 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jill SchiaparelliExecutive Officer, Director
- Thomas Shehab, MDDirector
- Kevin WassersteinDirector
- Offering amount
- $22.1M
- Amount sold
- $12.9M
- Minimum investment
- $1
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.